Similar Items: The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
- Association of Frequent Short-Acting Beta-Agonist Inhaler Prescriptions with Acute Cardiovascular Events
- Mapping EQ-5D-5L Score From SGRQ in Patients with Asthma and/or COPD in NOVELTY
- Review of Challenges in Performing Real-World Evidence Studies for Nonprescription Products
- Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study
- INSIGHTS Asthma Pragmatic Registry – A Pragmatic Approach to High-Validity Real-World Evidence for Asthma
- Validation and Final Results from the First Cardiac Lead Post-Approval Study Using Real-World Data